Patient profiles and early response in patients with systemic lupus erythematosus initiating anifrolumab: interim analysis from the ongoing multicentre observational REVEAL study

This publication has 34 references indexed in Scilit:

• Assessment of Clinical Response to Anifrolumab in Patients With Refractory Discoid Lupus Erythematosus
  JAMA Dermatology, 2023
• Treatment With Anifrolumab for Discoid Lupus Erythematosus
  JAMA Dermatology, 2023
• Association of Modified Systemic Lupus Erythematosus Responder Index Attainment With Long‐Term Clinical Outcomes: A Five‐Year Prospective Study
  Arthritis & Rheumatology, 2022
• A Randomized, Placebo‐Controlled Phase III Extension Trial of the Long‐Term Safety and Tolerability of Anifrolumab in Active Systemic Lupus Erythematosus
  Arthritis & Rheumatology, 2022
• Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real‐Life Setting
  Arthritis & Rheumatology, 2020
• Treatment Target in Newly Diagnosed Systemic Lupus Erythematosus: The Association of Lupus Low Disease Activity State and Remission With Lower Accrual of Early Damage
  Arthritis Care & Research, 2019
• Development and Validation of the Lupus Impact Tracker: A Patient‐Completed Tool for Clinical Practice to Assess and Monitor the Impact of Systemic Lupus Erythematosus
  Arthritis Care & Research, 2014
• The type I interferon system in the development of lupus
  Seminars in Immunology, 2011
• Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support
  Journal of Biomedical Informatics, 2009
• The development and initial validation of the systemic lupus international collaborating clinics/American college of rheumatology damage index for systemic lupus erythematosus
  Arthritis & Rheumatism, 1996